![](https://investorshub.advfn.com/uicon/610450.png?cb=1520856240)
Friday, June 02, 2017 12:39:18 PM
http://raps.org/regulatory-focus/news/2017/05/05/27488/FDA-proposal-explains-uses-for-new-innovation-funds/
FDA’s Center for Biologics Evaluation and Research (CBER) will also use innovation funds to facilitate a public process with the National Institute of Standards and Technology and other stakeholders to coordinate and prioritize the development of standards and consensus definitions of terms for new regenerative products. Meanwhile, use of FDA’s new Regenerative Medicine Advanced Therapy (RMAT) designation created under Cures has already begun. - See more at: http://raps.org/regulatory-focus/news/2017/05/05/27488/FDA-proposal-explains-uses-for-new-innovation-funds/#sthash.3Ts7nFHB.dpuf
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM